VLTO Veralto

FY2024 10-K
Filed: Feb 25, 2025
Health Care
Instruments For Meas & Testing of Electricity & Elec SignalsSEC EDGAR

Veralto (VLTO) filed its fiscal year 2024 10-K annual report with the SEC on Feb 25, 2025. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2024 10-K

Business Overview

  • Core business model: global industrial and consumer product sales with geographic and industry diversity
  • Emphasis on acquisitions, investments, strategic partnerships to drive innovation and higher margin products
+3 more insights

Risk Factors

  • Indemnification liability risk with significant deductible on director/officer insurance coverage potentially exceeding insured amounts
  • Goodwill impairment sensitivity with reporting unit fair values 144%-783% above carrying value after hypothetical 10% valuation decrease
+3 more insights

Financial Summary
XBRL

Revenue

$5.2B

Net Income

$833M

Gross Margin

59.8%

Operating Margin

23.3%

Net Margin

16.0%

ROE

40.9%

Total Assets

$6.4B

EPS (Diluted)

$3.34

Operating Cash Flow

$875M

Source: XBRL data from Veralto FY2024 10-K filing on SEC EDGAR. All figures in USD.

Other Veralto Annual Reports

Get deeper insights on Veralto

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available